Have we found the solution to reversing aging in magic mushrooms? Scientists believe they're closer than ever
Remove Ads
From psychedelics to prolonged Life
Tired of too many ads?
Remove Ads
What did the study say?
Not just a longer life, a better one
Tired of too many ads?
Remove Ads
Beyond mental health
What's Next?
Researchers at Emory University have found that psilocin, the active metabolite of psilocybin, the hallucinogenic compound in magic mushrooms , can significantly extend lifespan and improve biological health in mice. The study, published this week in 'Nature Partner Journals: Aging ', raises the tantalizing question: could psychedelic therapy offer more than just mental health benefits and actually delay aging in humans?The study's results are as striking as they are unexpected. Mice administered psilocybin lived nearly 30 percent longer than their untreated peers, and they aged more gracefully, too. Treated mice displayed fuller, healthier coats, fewer white hairs, and more physical mobility.In parallel lab tests, human skin and lung cells exposed to psilocin demonstrated a 50 percent increase in lifespan. These results, researchers say, suggest that psilocybin may act on cellular aging mechanisms at a foundational level."Psilocybin doesn't just alter consciousness; it appears to alter cellular fate," said Dr. Louise Hecker, senior author of the study and former associate professor at Emory University. 'Even when administered late in life, psilocybin still extended survival and improved physical function, which is clinically meaningful for aging populations.'Dr. Hecker, now at Baylor College of Medicine, led the team that tracked the impact of monthly psilocybin treatments on 19-month-old mice, roughly equivalent to 60- to 65-year-old humans. Mice received an initial low dose of 5 milligrams of psilocybin, followed by 15 mg monthly for ten months.The study revealed that psilocybin doesn't simply slow aging; it appears to address the biological hallmarks of aging itself. Treated mice showed reduced oxidative stress, a key driver of age-related diseases, as well as preserved telomere length and improved DNA repair.Telomeres are the protective caps at the ends of chromosomes. As we age, they naturally shorten, increasing vulnerability to cancer, neurodegenerative conditions, and heart disease. Psilocin appears to protect these cellular structures, suggesting its potential as a broad-spectrum anti-aging agent.'These mechanisms are fundamental to aging and disease,' Dr. Hecker noted. 'Psilocybin may be the first drug of its kind to act on all of them simultaneously.'For Dr. Ali John Zarrabi, Director of Psychedelic Research in Emory's Department of Psychiatry and a co-investigator on the study, the implications go far beyond lifespan.'As a palliative care physician, I often ask: what's the point of living longer if it's with more pain, more dependency, and less dignity?' Zarrabi said. 'What excited us is that these mice weren't just surviving longer, they were thriving. That suggests psilocybin could help promote healthy aging, not just extended aging.'The findings come amid growing global interest in anti-aging science. With the US anti-aging market now surpassing $500 million annually, the search for therapies that extend both life and vitality has become a high-stakes frontier of medical research.The study's release also follows a sobering report from KFF showing that US life expectancy, currently 78.4 years, lags significantly behind that of other developed nations. From 1980 to 2022, American lifespan increased by only 4.7 years, compared to a 7.9-year increase elsewhere.Although psilocybin has gained attention primarily for its powerful effects on treatment-resistant depression, anxiety, and PTSD , this study is one of the first to examine its systemic effects on aging.'Most cells in the human body express serotonin receptors ,' Hecker explained, 'which suggests that psilocybin could exert influence far beyond the brain.' This broad receptor presence may be why the compound had such wide-ranging impacts on both cell health and whole-body physiology.Zarrabi confirmed that Emory is actively participating in Phase II and III clinical trials for psilocybin-assisted therapy for depression. He now hopes this study will spark expanded research into psilocybin's potential anti-aging benefits in humans."If psilocybin gets FDA approval for depression in 2027," he said, "it may pave the way for trials investigating whether improved mental health can lead to improved physical health, and even extended lifespan."While the findings are promising, experts caution that much more research is needed before psilocybin can be considered a legitimate anti-aging treatment for humans.'We're just scratching the surface,' said Zarrabi. 'What we need now are long-term human trials in aging populations to explore not only the safety, but the functional benefits of psilocybin as a systemic therapeutic.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
7 hours ago
- Hans India
Proposed new criteria to impact obesity prevalence, say researchers
An international team of researchers has found that obesity prevalence would shift significantly under proposed new criteria that could hinder the prevention and early detection of serious health conditions. The study, published in Plos Global Public Health, analysed data from 56 countries to compare the prevalence of pre-clinical and clinical obesity using the existing BMI criteria with what the prevalence would be under the proposed criteria that requires at least one health condition to already be present before a person is considered clinically obese, such as diabetes, hypertension, or high cholesterol. 'Obesity is a serious problem and the definitions we use have implications for clinical treatment, health expenditures, disease surveillance, and for peoples' awareness of their own health risks. So, it is important to understand how much any new definition would impact the prevalence of obesity,' said lead author Rodrigo Carrillo-Larco, assistant professor of global health at Emory University's Rollins School of Public Health. The study was authored by researchers from Emory University and Johns Hopkins University in the US, University of Queensland in Australia, Zhejiang University School of Medicine in China, and Universidad Peruana Cayetano Heredia and Universidad Cientifica del Sur in Peru. When the additional health issues were included into the criteria for obesity, the prevalence dropped significantly among the 142,250 adults surveyed—with some nations seeing a drop of more than 50 per cent—but the results varied by nation and gender. For example, the East African nation of Malawi had among the highest decreases in obesity prevalence under the proposed definition, but the decline was uneven among men (68 per cent) and women (53 per cent). While the new definition could be more aligned with current disease risk, the researchers urged caution before considering a shift in obesity surveillance to the proposed standard because doing so would create substantial challenges in terms of measurement, equity, and implementation. And for individuals who would no longer be considered obese, it could provide a dangerous false sense of security. 'At the population level we would expect the prevalence of obesity to drop, but we should be mindful that it's an artificial drop because the new definition is more strict or complex—that reduction in obesity is not real,' Carrillo-Larco said.
Economic Times
5 days ago
- Economic Times
Have we found the solution to reversing aging in magic mushrooms? Scientists believe they're closer than ever
Tired of too many ads? Remove Ads From psychedelics to prolonged Life Tired of too many ads? Remove Ads What did the study say? Not just a longer life, a better one Tired of too many ads? Remove Ads Beyond mental health What's Next? Researchers at Emory University have found that psilocin, the active metabolite of psilocybin, the hallucinogenic compound in magic mushrooms , can significantly extend lifespan and improve biological health in mice. The study, published this week in 'Nature Partner Journals: Aging ', raises the tantalizing question: could psychedelic therapy offer more than just mental health benefits and actually delay aging in humans?The study's results are as striking as they are unexpected. Mice administered psilocybin lived nearly 30 percent longer than their untreated peers, and they aged more gracefully, too. Treated mice displayed fuller, healthier coats, fewer white hairs, and more physical parallel lab tests, human skin and lung cells exposed to psilocin demonstrated a 50 percent increase in lifespan. These results, researchers say, suggest that psilocybin may act on cellular aging mechanisms at a foundational level."Psilocybin doesn't just alter consciousness; it appears to alter cellular fate," said Dr. Louise Hecker, senior author of the study and former associate professor at Emory University. 'Even when administered late in life, psilocybin still extended survival and improved physical function, which is clinically meaningful for aging populations.'Dr. Hecker, now at Baylor College of Medicine, led the team that tracked the impact of monthly psilocybin treatments on 19-month-old mice, roughly equivalent to 60- to 65-year-old humans. Mice received an initial low dose of 5 milligrams of psilocybin, followed by 15 mg monthly for ten study revealed that psilocybin doesn't simply slow aging; it appears to address the biological hallmarks of aging itself. Treated mice showed reduced oxidative stress, a key driver of age-related diseases, as well as preserved telomere length and improved DNA are the protective caps at the ends of chromosomes. As we age, they naturally shorten, increasing vulnerability to cancer, neurodegenerative conditions, and heart disease. Psilocin appears to protect these cellular structures, suggesting its potential as a broad-spectrum anti-aging agent.'These mechanisms are fundamental to aging and disease,' Dr. Hecker noted. 'Psilocybin may be the first drug of its kind to act on all of them simultaneously.'For Dr. Ali John Zarrabi, Director of Psychedelic Research in Emory's Department of Psychiatry and a co-investigator on the study, the implications go far beyond lifespan.'As a palliative care physician, I often ask: what's the point of living longer if it's with more pain, more dependency, and less dignity?' Zarrabi said. 'What excited us is that these mice weren't just surviving longer, they were thriving. That suggests psilocybin could help promote healthy aging, not just extended aging.'The findings come amid growing global interest in anti-aging science. With the US anti-aging market now surpassing $500 million annually, the search for therapies that extend both life and vitality has become a high-stakes frontier of medical study's release also follows a sobering report from KFF showing that US life expectancy, currently 78.4 years, lags significantly behind that of other developed nations. From 1980 to 2022, American lifespan increased by only 4.7 years, compared to a 7.9-year increase psilocybin has gained attention primarily for its powerful effects on treatment-resistant depression, anxiety, and PTSD , this study is one of the first to examine its systemic effects on aging.'Most cells in the human body express serotonin receptors ,' Hecker explained, 'which suggests that psilocybin could exert influence far beyond the brain.' This broad receptor presence may be why the compound had such wide-ranging impacts on both cell health and whole-body confirmed that Emory is actively participating in Phase II and III clinical trials for psilocybin-assisted therapy for depression. He now hopes this study will spark expanded research into psilocybin's potential anti-aging benefits in humans."If psilocybin gets FDA approval for depression in 2027," he said, "it may pave the way for trials investigating whether improved mental health can lead to improved physical health, and even extended lifespan."While the findings are promising, experts caution that much more research is needed before psilocybin can be considered a legitimate anti-aging treatment for humans.'We're just scratching the surface,' said Zarrabi. 'What we need now are long-term human trials in aging populations to explore not only the safety, but the functional benefits of psilocybin as a systemic therapeutic.'
Time of India
5 days ago
- Time of India
Have we found the solution to reversing aging in magic mushrooms? Scientists believe they're closer than ever
Researchers at Emory University have found that psilocin, the active metabolite of psilocybin, the hallucinogenic compound in magic mushrooms , can significantly extend lifespan and improve biological health in mice. The study, published this week in 'Nature Partner Journals: Aging', raises the tantalizing question: could psychedelic therapy offer more than just mental health benefits and actually delay aging in humans? From psychedelics to prolonged Life Explore courses from Top Institutes in Please select course: Select a Course Category Data Science Project Management Digital Marketing Data Science MBA CXO Degree Management Data Analytics Technology Leadership Operations Management Cybersecurity Healthcare MCA PGDM Others others Finance Product Management healthcare Design Thinking Public Policy Artificial Intelligence Skills you'll gain: Duration: 30 Weeks IIM Kozhikode SEPO - IIMK-AI for Senior Executives India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months E&ICT Academy, Indian Institute of Technology Guwahati CERT-IITG Prof Cert in DS & BA with GenAI India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months IIT Madras CERT-IITM Advanced Cert Prog in AI and ML India Starts on undefined Get Details Skills you'll gain: Duration: 11 Months E&ICT Academy, Indian Institute of Technology Guwahati CERT-IITG Postgraduate Cert in AI and ML India Starts on undefined Get Details Skills you'll gain: Duration: 10 Months IIM Kozhikode CERT-IIMK DABS India Starts on undefined Get Details The study's results are as striking as they are unexpected. Mice administered psilocybin lived nearly 30 percent longer than their untreated peers, and they aged more gracefully, too. Treated mice displayed fuller, healthier coats, fewer white hairs, and more physical mobility. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo In parallel lab tests, human skin and lung cells exposed to psilocin demonstrated a 50 percent increase in lifespan. These results, researchers say, suggest that psilocybin may act on cellular aging mechanisms at a foundational level. "Psilocybin doesn't just alter consciousness; it appears to alter cellular fate," said Dr. Louise Hecker, senior author of the study and former associate professor at Emory University. 'Even when administered late in life, psilocybin still extended survival and improved physical function, which is clinically meaningful for aging populations.' Live Events Dr. Hecker, now at Baylor College of Medicine, led the team that tracked the impact of monthly psilocybin treatments on 19-month-old mice, roughly equivalent to 60- to 65-year-old humans. Mice received an initial low dose of 5 milligrams of psilocybin, followed by 15 mg monthly for ten months. What did the study say? The study revealed that psilocybin doesn't simply slow aging; it appears to address the biological hallmarks of aging itself. Treated mice showed reduced oxidative stress, a key driver of age-related diseases, as well as preserved telomere length and improved DNA repair. Telomeres are the protective caps at the ends of chromosomes. As we age, they naturally shorten, increasing vulnerability to cancer, neurodegenerative conditions, and heart disease. Psilocin appears to protect these cellular structures, suggesting its potential as a broad-spectrum anti-aging agent. 'These mechanisms are fundamental to aging and disease,' Dr. Hecker noted. 'Psilocybin may be the first drug of its kind to act on all of them simultaneously.' Not just a longer life, a better one For Dr. Ali John Zarrabi, Director of Psychedelic Research in Emory's Department of Psychiatry and a co-investigator on the study, the implications go far beyond lifespan. 'As a palliative care physician, I often ask: what's the point of living longer if it's with more pain, more dependency, and less dignity?' Zarrabi said. 'What excited us is that these mice weren't just surviving longer, they were thriving. That suggests psilocybin could help promote healthy aging, not just extended aging.' The findings come amid growing global interest in anti-aging science. With the US anti-aging market now surpassing $500 million annually, the search for therapies that extend both life and vitality has become a high-stakes frontier of medical research. The study's release also follows a sobering report from KFF showing that US life expectancy, currently 78.4 years, lags significantly behind that of other developed nations. From 1980 to 2022, American lifespan increased by only 4.7 years, compared to a 7.9-year increase elsewhere. Beyond mental health Although psilocybin has gained attention primarily for its powerful effects on treatment-resistant depression, anxiety, and PTSD , this study is one of the first to examine its systemic effects on aging. 'Most cells in the human body express serotonin receptors ,' Hecker explained, 'which suggests that psilocybin could exert influence far beyond the brain.' This broad receptor presence may be why the compound had such wide-ranging impacts on both cell health and whole-body physiology. Zarrabi confirmed that Emory is actively participating in Phase II and III clinical trials for psilocybin-assisted therapy for depression. He now hopes this study will spark expanded research into psilocybin's potential anti-aging benefits in humans. "If psilocybin gets FDA approval for depression in 2027," he said, "it may pave the way for trials investigating whether improved mental health can lead to improved physical health, and even extended lifespan." What's Next? While the findings are promising, experts caution that much more research is needed before psilocybin can be considered a legitimate anti-aging treatment for humans. 'We're just scratching the surface,' said Zarrabi. 'What we need now are long-term human trials in aging populations to explore not only the safety, but the functional benefits of psilocybin as a systemic therapeutic.'
